CCM
BMY icon

Chiron Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Chiron Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.6M Buy
+191,288
New +$11.2M 11.89% 1
2025
Q3 		$12.8M Sell
283,373
-3,040
-1% -$142K 10.94% 1
2025
Q2 		$13.3M Sell
286,413
-13,195
-4% -$648K 11.54% 1
2025
Q1 		$18.3M Sell
299,608
-109,920
-27% -$6.41M 16.61% 1
2024
Q4 		$23.2M Sell
409,528
-35,078
-8% -$1.96M 21.86% 1
2024
Q3 		$23M Sell
444,606
-7,778
-2% -$365K 20.36% 1
2024
Q2 		$18.8M Buy
452,384
+5,664
+1% +$253K 17.94% 1
2024
Q1 		$24.2M Buy
446,720
+2,105
+0.5% +$107K 22% 1
2023
Q4 		$22.8M Sell
444,615
-25,095
-5% -$1.32M 19.85% 1
2023
Q3 		$27.3M Sell
469,710
-8,963
-2% -$549K 23.45% 1
2023
Q2 		$30.6M Buy
478,673
+1,538
+0.3% +$103K 24.24% 1
2023
Q1 		$33.1M Sell
477,135
-9,013
-2% -$636K 22.99% 1
2022
Q4 		$35M Sell
486,148
-35,991
-7% -$2.71M 24.33% 1
2022
Q3 		$37.1M Sell
522,139
-15,058
-3% -$1.09M 24.94% 1
2022
Q2 		$41.4M Sell
537,197
-80,823
-13% -$6.16M 26.09% 1
2022
Q1 		$45.1M Sell
618,020
-95,696
-13% -$6.43M 28.45% 1
2021
Q4 		$44.5M Sell
713,716
-370
-0.1% -$21.7K 32.12% 1
2021
Q3 		$42.3M Buy
714,086
+50,004
+8% +$3.29M 30.82% 1
2021
Q2 		$44.4M Sell
664,082
-100,971
-13% -$6.58M 36.97% 1
2021
Q1 		$48.3M Sell
765,053
-7,414
-1% -$461K 40.99% 1
2020
Q4 		$47.9M Sell
772,467
-11,612
-1% -$714K 39.45% 1
2020
Q3 		$47.3M Buy
+784,079
New +$47.2M 38.07% 1

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Chiron Capital Management's BMY Position: Q1 2026 in Review

Chiron Capital Management opened a new position in Bristol-Myers Squibb (BMY) in Q1 2026: 191,288 shares worth $11.6M. The stake represents 11.89% of the portfolio and ranks #1 among its holdings. This is a return to the name: Chiron Capital Management previously reported a position in BMY as recently as Q3 2025.

Chiron Capital Management first reported a position in BMY in Q3 2020 and has held it in 22 quarters since. The position peaked at $48.3M in Q1 2021. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Chiron Capital Management held 191,288 shares of Bristol-Myers Squibb worth $11.6M as of Q1 2026.
  • Bristol-Myers Squibb was a new Chiron Capital Management position in Q1 2026.
  • Bristol-Myers Squibb made up 11.89% of Chiron Capital Management's portfolio in Q1 2026, its #1 holding.
  • Chiron Capital Management first reported a position in Bristol-Myers Squibb in Q3 2020 and has held it in 22 quarters since.
  • Chiron Capital Management's Bristol-Myers Squibb position peaked at $48.3M in Q1 2021.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Chiron Capital Management's 13F filing for Q1 2026, filed 21 Apr 2026.